Abstract
Atherosclerotic renal artery disease is often associated with disease elsewhere in the cardiovascular system. In the setting of heart failure, morbidity and mortality are significantly increased in those patients with co-existent renovascular disease. As understanding of this cardiorenal interaction evolves, it is clear that awareness and early interventions with targeted medical therapies aimed at reducing atherosclerotic burden are essential to prevent progression of renovascular disease and cardiovascular events, with further targeted revascularization possibly playing a role in appropriately selected patients. This article reviews the current diagnostic and treatment modalities for renovascular disease, as well as highlighting some of the key trials of revascularization vs. medical therapy for treatment of this condition.
Originally published in Bakris, The Kidney in Heart Failure, ISBN: 978-1-4614-3693-5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Am J Kidney Dis. 2004;43:S101–6.
De Bruyne B, Manoharan G, Piljs NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–5.
Conlon PJ, Little MA, Pieper K, et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490–7.
Macdowall P, Kalra PA, O’Donoghue DJ, et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998;352:13–6.
Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renal vascular disease in United States patients aged 67 years and older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293–301.
Kane GC, Xu N, Mistrik E, et al. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2010;25:813–20.
Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;10:1987–96.
Rao MV, Murray P, Yancy C. Management of heart failure with renal artery ischaemia. Heart Fail Clin. 2008;4:465–78.
Textor SC. Ischaemic nephropathy: where are we now? J Am Soc Nephrol. 2004;15:1974–82.
Dworkin LD, Cooper CJ. Renal-artery stenosis. N Eng J Med. 2009;361:1972–8.
de Silva R, Nikitin NP, Bhandari S, et al. Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur Heart J. 2005;26:1596–605.
Coyler WR, Cooper CJ. Cardiovascular morbidity and mortality and renal artery stenosis. Prog Cardiovasc Dis. 2009;52:238–42.
Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int. 2007;72:260–4.
Simon J. Stenting atherosclerotic renal arteries: time to be less aggressive. Cleve Clin J Med. 2010;77:178–89.
van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch renal Artery Stenosis Intervention cooperative Study Group. N Engl J Med. 2000;342:1007–14.
Bax L, Woittiez AJ, Kouweberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150: 840–8.
The ASTRAL Investigators, Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.
Dworkin LD, Jamerson KA. The case against angioplasty and stenting of atherosclerotic renal artery stenosis. Circulation. 2007;115:271–6.
Cooper CJ, Murphy TP. The case for angioplasty and stenting of atherosclerotic renal artery stenosis. Circulation. 2007;115:263–70.
van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet. 1999;353:282–6.
Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244–9.
Weinrauch LA, D’Elia JA. Renal artery stenosis: “fortuitous diagnosis,” problematic therapy. J Am Coll Cardiol. 2004;43:1614–6.
Stockx L, Wilms G, Baert AL. Prospects with renal artery stenting. Lancet. 1997;349:1115–6.
Dorros G, Jaff M, Mathiak L, et al. Four year follow up of Pamlaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642–7.
Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal artery stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78–85.
Holden A, Hill A, Jaff MR, et al. Renal artery stent revascularization with embolic protection in patients with ischaemic nephropathy. Kidney Int. 2006;70:948–55.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Roy, A.K., Murray, P. (2012). Management of Heart Failure with Renal Artery Ischaemia. In: Bakris, G. (eds) Managing the Kidney when the Heart is Failing. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-3691-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3691-1_4
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-3690-4
Online ISBN: 978-1-4614-3691-1
eBook Packages: MedicineMedicine (R0)